157 related articles for article (PubMed ID: 31617673)
1. Challenging the indiscriminate use of temozolomide in pediatric high-grade gliomas: A review of past, current, and emerging therapies.
Guerra-García P; Marshall LV; Cockle JV; Ramachandran PV; Saran FH; Jones C; Carceller F
Pediatr Blood Cancer; 2020 Jan; 67(1):e28011. PubMed ID: 31617673
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016.
Rudà R; Pellerino A; Pace A; Carapella CM; Dealis C; Caroli M; Faedi M; Bello L; Migliore E; Marchese G; Bertero L; Cassoni P; Soffietti R
J Neurooncol; 2019 Oct; 145(1):115-123. PubMed ID: 31556015
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
Wahl M; Phillips JJ; Molinaro AM; Lin Y; Perry A; Haas-Kogan DA; Costello JF; Dayal M; Butowski N; Clarke JL; Prados M; Nelson S; Berger MS; Chang SM
Neuro Oncol; 2017 Feb; 19(2):242-251. PubMed ID: 27571885
[TBL] [Abstract][Full Text] [Related]
4. Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities.
Haase S; Nuñez FM; Gauss JC; Thompson S; Brumley E; Lowenstein P; Castro MG
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348922
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis Reveals a 4-Gene Signature in Predicting Response to Temozolomide in Low-Grade Glioma Patients.
Wang Q; He Z; Chen Y
Cancer Control; 2019; 26(1):1073274819855118. PubMed ID: 31167546
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
7. Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma.
Tom MC; Park DYJ; Yang K; Leyrer CM; Wei W; Jia X; Varra V; Yu JS; Chao ST; Balagamwala EH; Suh JH; Vogelbaum MA; Barnett GH; Prayson RA; Stevens GHJ; Peereboom DM; Ahluwalia MS; Murphy ES
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1106-1112. PubMed ID: 31461674
[TBL] [Abstract][Full Text] [Related]
8. Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.
Izquierdo C; Alentorn A; Idbaih A; Simó M; Kaloshi G; Ricard D; Barritault M; Meyronet D; Bruna J; Honnorat J; Delattre JY; Ducray F
J Neurooncol; 2018 Feb; 136(3):533-539. PubMed ID: 29143276
[TBL] [Abstract][Full Text] [Related]
9. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for temozolomide.
Rinne ML; Wen PY
Oncology (Williston Park); 2015 Apr; 29(4):265, 275. PubMed ID: 25952491
[No Abstract] [Full Text] [Related]
10. How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study.
Perwein T; Giese B; Nussbaumer G; von Bueren AO; van Buiren M; Benesch M; Kramm CM
J Neurooncol; 2023 Feb; 161(3):525-538. PubMed ID: 36720762
[TBL] [Abstract][Full Text] [Related]
11. Molecular characteristics of pediatric non-ependymal, non‑pilocytic gliomas associated with resistance to temozolomide.
Ezaki T; Sasaki H; Hirose Y; Miwa T; Yoshida K; Kawase T
Mol Med Rep; 2011; 4(6):1101-5. PubMed ID: 21874248
[TBL] [Abstract][Full Text] [Related]
12. Could upfront temozolomide chemotherapy postpone the need for radiotherapy in young patients with high-risk low-grade gliomas?
Li ZY; Yuan SW; Song YY; Hameed NUF; Chen H; Zhuang DX; Lu JF; Gong FY; Aibaidula A; Shi ZF; Wu S; Guo QH; Wu JS
Chin Med J (Engl); 2021 Mar; 134(11):1356-1358. PubMed ID: 33788781
[No Abstract] [Full Text] [Related]
13. Dynamic history of low-grade gliomas before and after temozolomide treatment.
Ricard D; Kaloshi G; Amiel-Benouaich A; Lejeune J; Marie Y; Mandonnet E; Kujas M; Mokhtari K; Taillibert S; Laigle-Donadey F; Carpentier AF; Omuro A; Capelle L; Duffau H; Cornu P; Guillevin R; Sanson M; Hoang-Xuan K; Delattre JY
Ann Neurol; 2007 May; 61(5):484-90. PubMed ID: 17469128
[TBL] [Abstract][Full Text] [Related]
14. Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas.
De Vos FY; Gijtenbeek JM; Bleeker-Rovers CP; van Herpen CM
Crit Rev Oncol Hematol; 2013 Mar; 85(3):373-82. PubMed ID: 22925496
[TBL] [Abstract][Full Text] [Related]
15. Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies.
van den Bent MJ
Semin Oncol; 2003 Dec; 30(6 Suppl 19):39-44. PubMed ID: 14765384
[TBL] [Abstract][Full Text] [Related]
16. The use of temozolomide in recurrent malignant gliomas.
Gaya A; Rees J; Greenstein A; Stebbing J
Cancer Treat Rev; 2002 Apr; 28(2):115-20. PubMed ID: 12297119
[TBL] [Abstract][Full Text] [Related]
17. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
Levin VA
Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
[No Abstract] [Full Text] [Related]
18. Temozolomide and treatment of malignant glioma.
Friedman HS; Kerby T; Calvert H
Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas.
Liang ML; Hsieh TH; Ng KH; Tsai YN; Tsai CF; Chao ME; Liu DJ; Chu SS; Chen W; Liu YR; Liu RS; Lin SC; Ho DM; Wong TT; Yang MH; Wang HW
Oncotarget; 2016 Apr; 7(15):19723-37. PubMed ID: 26933822
[TBL] [Abstract][Full Text] [Related]
20. MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway.
Tan Z; Zhao J; Jiang Y
Cancer Med; 2018 Mar; 7(3):913-921. PubMed ID: 29473317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
